NCT01402687
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Non-Hodgkin's Lymphoma
Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.
250 public trials
20 recruiting studies
Non-Hodgkin's Lymphoma trial results
NCT01118845
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Diffuse, Mantle Cell Lymphoma, Lymphoma, Follicular Lymphoma, +16 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Akita, Japan
- Matsuyama, Ehime, Japan
- Fukuoka, Japan
NCT00685997
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +10 more
- Locations
-
- Academic Medical Center Amsterdam Amsterdam, North Holland, Netherlands
- Meander Medical Center Amersfoort Amersfoort, Utrecht, Netherlands
- University Medical Center Utrecht Utrecht, Netherlands
NCT00352846
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00969462
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Departmetn of Medicine. Meir Medical Center Kfar Saba, Israel
NCT01149668
- Conditions
- Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +29 more
- Locations
-
- Northwestern Univ. Med School Chicago, Illinois, United States
- Horizon Oncology Center Lafayette, Indiana, United States
- Nebraska Methodist Hospital Omaha, Nebraska, United States
- Univ. of Nebraska Medical Center Omaha, Nebraska, United States
NCT00944905
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
- Locations
-
- Yale University School of Medicine New Haven, Connecticut, United States
- Emory University Winship Cancer Center Atlanta, Georgia, United States
- The University of Chicago Chicago, Illinois, United States
- University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
NCT00421213
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +14 more
- Locations
-
- Miami, Florida, United States
- Chicago, Illinois, United States
- Bethesda, Maryland, United States
- Fargo, North Dakota, United States
Completed
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
NCT00051025
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Central Baptist Hospital Lexington, Kentucky, United States
- Hematology and Oncology Services Metairie, Louisiana, United States
Completed
Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
NCT00312845
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- East Alabama Medical Center Opelika, Alabama, United States
- Central Hematology Oncology Medical Group, Inc Alhambra, California, United States
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- Providence Saint Joseph Medical Center Burbank, California, United States